A prospective, observational study in patients receiving adjuvant Nivolumab therapy for resected melanoma in Australia.

  • Brady, Benjamin (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date12/12/191/12/21

Keywords

  • Melanoma
  • Nivolumab
  • Clinical trial